Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
MasTec
MTZ
$20.5B
| $16.9M | 0.03% |
851,427
-504,201
| -37% | -$9.43M |
|
|
AGEN
702
Agenus
AGEN
$345M
| $16.9M | 0.03% |
99,500
+11,215
| +13% | +$1.59M |
|
|
BKI
703
DELISTED
Black Knight, Inc. Common Stock
BKI
| $16.8M | 0.03% |
+545,201
| New | +$15.7M |
|
704
Quanta Services
PWR
$92.7B
| $16.8M | 0.03% |
583,068
-1,017,293
| -64% | -$29.7M |
|
|
BBT
705
Beacon Financial Corp
BBT
$2.65B
| $16.8M | 0.03% |
589,004
+35,706
| +6% | +$997K |
|
706
Toro Company
TTC
$9.47B
| $16.8M | 0.03% |
494,808
-336,866
| -41% | -$11.6M |
|
707
Yum! Brands
YUM
$42.9B
| $16.8M | 0.03% |
258,937
-214,445
| -45% | -$13.6M |
|
|
ORIG
708
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
| $16.7M | 0.03% |
355
+109
| +44% | +$7.22M |
|
709
CALL
iShares MSCI Germany ETF
EWG
$1.72B
| $16.7M | 0.03% |
+600,000
| New | +$17.8M |
|
710
CALL
Eli Lilly
LLY
$1.11T
| $16.7M | 0.03% |
200,000
| – | – |
|
|
TCF
711
DELISTED
TCF Financial Corporation Common Stock
TCF
| $16.7M | 0.03% |
504,430
-2,188
| -0.4% | -$69K |
|
|
EQC
712
DELISTED
Equity Commonwealth
EQC
| $16.7M | 0.03% |
649,314
-167,045
| -20% | -$4.35M |
|
713
CALL
General Motors
GM
$76.3B
| $16.7M | 0.03% |
+500,000
| New | +$17.8M |
|
|
KING
714
DELISTED
KING DIGITAL ENTMT PLC ORD SHS (IRL)
KING
| $16.6M | 0.03% |
1,168,372
+605,431
| +108% | +$9.38M |
|
715
Jabil
JBL
$31.9B
| $16.6M | 0.03% |
779,732
+384,878
| +97% | +$9.07M |
|
716
Duke Energy
DUK
$95.1B
| $16.6M | 0.03% |
235,034
+92,605
| +65% | +$7M |
|
717
Korn Ferry
KFY
$4.35B
| $16.5M | 0.03% |
475,711
+388,418
| +445% | +$12.8M |
|
718
DHT Holdings
DHT
$3.18B
| $16.4M | 0.03% |
2,116,352
-205,126
| -9% | -$1.61M |
|
719
Chubb
CB
$133B
| $16.4M | 0.03% |
161,444
-80,854
| -33% | -$8.71M |
|
720
Quest Diagnostics
DGX
$26.9B
| $16.4M | 0.03% |
226,249
+213,244
| +1,640% | +$15.7M |
|
|
TMHC
721
DELISTED
Taylor Morrison
TMHC
| $16.4M | 0.03% |
804,513
+553,693
| +221% | +$11M |
|
|
GLUU
722
DELISTED
Glu Mobile Inc.
GLUU
| $16.4M | 0.03% |
2,634,975
+172,678
| +7% | +$1.06M |
|
|
IVC
723
DELISTED
Invacare Corporation
IVC
| $16.2M | 0.03% |
750,908
-96,578
| -11% | -$2.05M |
|
724
Coca-Cola Europacific Partners
CCEP
$48.6B
| $16.2M | 0.03% |
372,449
-731,421
| -66% | -$32.8M |
|
725
Arbutus Biopharma
ABUS
$1.03B
| $16.2M | 0.03% |
1,363,025
+988,268
| +264% | +$15M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.